Mechanisms of Exacerbation of Asthma
NCT00594750 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 67
Last updated 2026-03-09
Summary
The purpose of this study is to identify the causes of asthma that were not previously suspected, to better understand the effects of inhaled steroids on asthma and to identify new way to treat asthma.
Conditions
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH -
University of California, San Francisco
lead OTHER
Principal Investigators
-
John V Fahy, M.D., M.Sc. · University of California, San Francisco
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-05-31
- Primary Completion
- 2019-11-01
- Completion
- 2025-08-05
Countries
- United States
Study Locations
More Related Trials
-
Mechanistic Insights From Bronchoscopy Airway Samples
NCT06105710 ·Status: RECRUITING
-
How Airway Remodeling and Hyperresponsiveness Contribute to Airflow Obstruction in Asthma
NCT00186693 ·Status: WITHDRAWN
-
Airflow Obstruction and Biomarkers of Airway Inflammation During and Following Acute Exacerbations of Childhood Asthma
NCT01227070 ·Status: COMPLETED
-
Progression of Airway Obstruction in Childhood Asthma
NCT00873873 ·Status: COMPLETED
-
Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma
NCT05035862 ·Status: TERMINATED ·Phase: PHASE1
-
Should Non-eosinophilic Asthmatic Subjects be Treated With Inhaled Corticosteroids?
NCT00509197 ·Status: TERMINATED ·Phase: NA
-
Analysis of Blood-based Biomarkers of Asthma
NCT00917787 ·Status: COMPLETED
-
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy
NCT02502890 ·Status: COMPLETED
-
Study to Assess Bronchospasm Potentially Induced by Next-Generation Propellant vs HFA Propellant in an MDI in Participants With Well/Partially Controlled Asthma
NCT05850494 ·Status: COMPLETED ·Phase: PHASE3
-
Molecular Mechanism of Asthma
NCT00180726 ·Status: WITHDRAWN ·Phase: NA
-
Inflammatory Processes in the Airway of Asthmatics With Persistent Bronchial Hyperreactivity
NCT00217854 ·Status: COMPLETED ·Phase: NA
-
Statin Treatment in Patients With Asthma
NCT00292201 ·Status: TERMINATED ·Phase: PHASE2
-
Predictive Factors for Exacerbation Outcome in Severe Refractory Asthmatics
NCT00721097 ·Status: TERMINATED
-
Residual Exacerbations With Mepolizumab
NCT04578171 ·Status: RECRUITING
-
Step-up to Medium Strength Triple Therapy vs High Strength ICS/LABA in Adult Asthmatics Uncontrolled on Medium Strength ICS/LABA
NCT05018598 ·Status: TERMINATED ·Phase: PHASE4
-
Mechanisms of Adverse Effects of Long-Acting Beta-Agonists in Asthma
NCT04503460 ·Status: UNKNOWN ·Phase: PHASE4
-
Lung Function Outcomes Following Removal of Airway Mucus Plugs in Patients With Asthma (FOCUS)
NCT05748912 ·Status: WITHDRAWN ·Phase: NA
-
Early Antiinflammatory Treatment of Asthma
NCT00567463 ·Status: TERMINATED ·Phase: NA
-
Role of microRNAs in T Cell-Driven Inflammation in Asthma
NCT01484691 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Lovastatin in Severe Persistent Asthma
NCT00689806 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Characteristics of Type 2- High Inflammatory Endotype of Asthma Using New Biomarkers From Peripheral Blood and Exhaled Air and Its Effect on the Outcome of Therapy
NCT05270278 ·Status: COMPLETED
-
Endotoxin and Bronchial Inflammation in Asthma
NCT00005550 ·Status: COMPLETED
-
Effect of an Inhaled Corticosteroid on Airway Gene Expression in Asthma
NCT00187499 ·Status: COMPLETED ·Phase: NA
-
Asthma/Steroid Withdrawal Study
NCT00395239 ·Status: TERMINATED ·Phase: PHASE4
-
12-Week Study in Adult Subjects With Asthma
NCT01516073 ·Status: COMPLETED ·Phase: PHASE2